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Ab stra ct
In to day’s heal th ca re system the pre va len ce of me di cal er ro rs see ms to be hi gh as sta ted by the re po rt of the In sti tu te of Me di ci ne (IOM). An er ror ra-
te of about 10% in cli ni cal me di cal la bo ra to ries has been con sis ten tly re por ted in the li te ra tu re. Mo st of the se er ro rs oc cur in the pre-a na lyti cal pha-
se. Be cau se on ly a sma ll num ber of er ro rs wi ll be seen in the ana lyti cal pha se, it is ve ry li ke ly that the se mig ht be ve ry of ten ig no red. This over view 
wi ll deal wi th the requi re men ts of qua li ty that is not ba sed on qua li ty con trol sam ple mea su re me nt on ly. The knowled ge of ana lyti cal in ter fe ren ces 
and cri ti cal sam ple qua li ty wi ll o3 er va luab le so lu tio ns to im pro ve the glo bal qua li ty of the to tal tes ti ng pro ce ss. So me spe cial areas of the ana lyti cal 
pro ce ss su ch as ca lib ra tion, qua li ty con trol, re fe ren ce in ter val, drug in ter fe ren ce, sta tis ti cal ana lysis, pa rap ro tei ns and vo lu me dis pla ce me nt e3 e ct 
wi ll be dis cus sed. Wi th so me exam ples from the li te ra tu re and per so nal in ves ti ga tion, the im pa ct of er ro rs in the ana lyti cal pro ce ss wi ll be bet ter 
un der stood and the exam ples wi ll he lp re du ci ng the num ber of ana lyti cal er ro rs and in ter fe ren ces, so that a mu ch bet ter pa tie nt sa fe ty can be 
gran ted.
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In tro duc tion
The re po rt of the In sti tu te of Me di ci ne (1) (IOM) 
has an im pa ct on la bo ra to ry me di ci ne in or der to 
re du ce er ro rs and blun de rs for bet ter pa tie nt sa fe-
ty. La bo ra to ry te st re sul ts ha ve a great im pa ct on 
cli ni cal de ci sio ns ma ki ng pro ces ses. This hi gh deg-
ree of in F uen ce, the qua li ty of la bo ra to ry tes ti ng 
and the re por ti ng is of ut mo st im por tan ce to any 
cli ni cian and cli ni cal che mi st. As mo st of the er ro rs 
in la bo ra to ry me di ci ne oc cur in the pre- and po st-
a na lyti cal pha ses, it is ve ry li ke ly that one wi ll for-
get to fo cus on the ana lyti cal pha se as we ll. Wi th 
ove rwhel mi ng de pen den ce on la bo ra to ry re sul ts 
re por ti ng and cli ni cia ns ma ki ng de ci sio ns so le ly 
ba sed on the se re por ts, it be co mes es sen tial for la-
bo ra to ry me di ci ne to set ve ry hi gh qua li ty stan-
dar ds, in or der to gra nt bo th bet ter pa tie nt sa fe ty 
and er rors re duc tion. La bo ra to ry me di ci ne is uni-
que in prac ti ce, and this is par ti cu lar ly true for cli-
ni cal che mis try la bo ra to ries. Un li ke ma ny ot her 
me di cal pro ces ses, ac ti vi ties in la bo ra to ry me di ci-
ne are pre ci se ly de 1  ned and are the re fo re mo re 
con trol lab le than a pro ce du re or treat me nt in an 
emer gen cy or cli ni cal de par tme nt. This over view 
wi ll deal wi th ana lyti cal in ter fe ren ces and ana lyti-
cal qua li ty is sues.
Re fe ren ce in ter val
Be fo re we sta rt to go in to fur ther de tai ls, we wi ll 
lea rn how to in ter pret da ta and va lues ob tained 
in the me di cal la bo ra to ry. An exam ple: a va lue of 
140 has on ly a ve ry li mi ted mea ni ng. One can not 
gi ve any sta te me nt if this va lue is hi gh or low or if 
this va lue rep re sen ts a nor mal or pat ho lo gi cal va-
lue. In the 1 e ld of cli ni cal la bo ra to ry one has to 
use a re fe ren ce in ter val, whi ch usual ly is cal cu la-
ted from a re fe ren ce po pu la tion of heal thy sta-
tus. Be cau se it is rat her diW   cu lt to get tho se in ter-
va ls, one has to ca re ful ly sear ch the li te ra tu re for 
it or re lay on in ter va ls pro vi ded by the diag nos tic 
ma nu fac tu re rs. Ve ry of ten the cli ni cian has to dif-
fe ren tia te be tween the sta tus “nor ma l” and “pat-
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ho lo gi ca l”. It is not that ea sy if va lues fa ll in the 
so-cal led “grey zo ne”, whe re a re pea ted mea su re-
me nt mig ht de li ver a di2 e re nt resu lt then the 
pre vious one (Fi gu re 1).
What is the co lor of a blood from a bla ck skin ned 
per son? Is the re a di2 e ren ce? No, the re is no di2 e-
ren ce in the co lor, but the va lues for heal thy or ill 
pa tien ts wi th di2 e re nt skin co lor may be co me im-
por ta nt. Gu der et al. ha ve showed the im pa ct of 
the ra ce on crea ti ne ki na se (CK) and amyla se ac ti-
vi ties (2). The CK ac ti vi ty in the bla ck skin ned po-
pu la tion is about two ti mes hig her than in whi te 
skin ned per so ns (3). The amyla se ac ti vi ty in the 
Asian po pu la tion that li ve in UK is two ti mes hig-
her then in the Bri ti sh po pu la tion (4).
A stu dy un der ta ken in 101 Ger man la bo ra to ries 
showed clear ly the prob lem of usi ng the cor re ct 
re fe ren ce in ter val (5). As an exam ple con cer ni ng 
po tas sium, the va lues for the low end of the in ter-
val was fou nd be tween 3.3 and 3.9 mmol/L, whi le 
the ran ge for the hi gh end was fou nd be tween 4.5 
and 5.6 mmol/L (Fi gu re 2). The re mig ht be good 
rea so ns for the di2 e ren ce, but a ques tion nai re in 
this stu dy showed that in mo st ca ses the la bo ra to-
ry was not ab le to explain from whi ch sour ce and 
li te ra tu re they ha ve ta ken the ran ge or sin ce what 
ti me they ha ve used the ran ge. Even in mo de rn 
textboo ks one may 1  nd re fe ren ces ran ges that ha-
ve been co pied from old li te ra tu re or the aut hor 
keep it sin ce the 1 r st edi tion of the book.
The sta te me nt of Ben son is sti ll va lid even if it was 
pub lis hed in 1972 (6).
The nor mal ran ge has had a va gue but com for ti ng 
ro le in la bo ra to ry medi ci ne. It loo ms on the ho ri-
zon of our con scious ne ss, per fec tly symmet ri cal li-
ke the Mou nt Fujiya ma, so mewhat mis ty in its 
mea ni ng, yet gra te ful ly re ve red and ac knowled-
ged. Far from bei ng sim ple and pu re, howe ver, li ke 
a che ris hed il lu sion of chil dhood, on clo se exa mi-
na tion it pro ves to be mad de nin gly com plex and 
is in deed one of the mo re stub bo rn and diW   cu lt 
prob le ms li mi ti ng the use ful ne ss of cli ni cal la bo ra-
to ry da ta.
FI GU RE 1. Dis tri bu tion cur ves of a po pu la tion wi th heal thy and 
di sea sed per so ns. A = ideal si tua tion – clear ly to dis cri mi na te. B 







FI GU RE 2. Re sul ts of a sur vey do ne in about 101 Ger man la bo ra to ries. The top li ne des cri bes the up per li mit and the bot tom li ne the 
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Vo lu me dis pla ce me nt e( e ct
Even mo de rn ana lyti cal syste ms are unab le to de-
te ct er ro rs crea ted by the pa tie nt sam ple. Frier et 
al. (7) ga ve a de tai led re po rt on the pa tie nt out co-
me of la bo ra to ry er ror and the re sul ti ng wro ng cli-
ni cal treat me nt due to the qua li ty of the sam ple.
A six yea rs old boy su2 e ri ng from dia be tes mel li-
tus was de li ve red to the hos pi tal. One of the la bo-
ra to ry 1 n din gs was a so dium con cen tra tion of 86 
mmol/L. The cli ni cia ns reac ted by trea ti ng the boy 
wi th physio lo gi cal sa li ne so lu tion over a ti me pe-
riod of se ven hou rs. Af ter that ti me anot her so-
dium mea su re me nt was reques ted and re sul ted in 
a con cen tra tion of 116 mmol/L. Now, bo th the cli-
ni cia ns and the la bo ra to ry re cog ni zed that this 
cou ld not be cli ni cally cor re ct. They fou nd the 
sam ple to be ve ry li pae mic and de ci ded to re mo ve 
the li pi ds. The cor re ct so dium con cen tra tion was 
thus fou nd to be 222 mmol/L. As a re su lt of the 
wro ng treat me nt fol lowed af ter the er ro neous la-
bo ra to ry va lue for so dium, the chi ld died from in-
trac ra nial he mor r ha ge.
We lear ned that the se rum or plas ma sam ple exis-
ted out of 93% water and 7% li pi ds and pro tei ns 
(8) in heal thy po pu la tion. If the re is a di sea se that 
chan ges the con cen tra tion of pro tei ns (e.g., mye-
lo ma) or li pi ds (e.g., li pid di sor der), one has to con-
si der an e2 e ct (i.e., bias) on la bo ra to ry tes ts (9) due 
to a vo lu me dis pla ce me nt e2 e ct. When per for mi-
ng a mea su re me nt in the wa ter pha se of the sam-
ple, it shou ld be re cog ni zed that pi pet ti ng er ro rs 
oc cur due to the dis pla ce me nt e2 e ct of the fa ts or 
pro tei ns in the sam ple. The hig her the con cen tra-
tion of li pi ds (es pe cial ly trig lyce ri des) or pro tei ns, 
the lower the wa ter pa rt in the sam ple. A di re ct 
mea su re me nt wi th ion se lec ti ve elec tro de wit hout 
a prior di lu tion of the sam ple wi ll he lp avoi di ng er-
ro neous low so dium va lues in ca se of pa tie nt wi th 
eit her li pid di sor der or from on co lo gy de par tme-
nt. Mo st ana lyze rs do not ha ve this di re ct mea su-
re me nt tec hno lo gy, and the re fo re the in stru me nt 
per for ms a di lu tion step prior to mea su re me nt 
and crea ti ng an er ror for low re sul ts. If the la bo ra-
to ry has no equip me nt that is mea su ri ng cor re ct 
va lues, a writ ten war ni ng re ma rk on the lab re po rt 
shou ld be pro vi ded to cli ni cia ns when the pa tie nt 
re su lt is ne ga ti ve ly bia sed due to hi gh li pid or pro-
tein con cen tra tio ns.
Pa rap ro tei ns
Pa rap ro tei ns ha ve been re por ted to in ter fe re wi th 
a num ber of rou ti ne cli ni cal che mis try met ho ds 
for mea su re me nt of to tal and di re ct bi li ru bin, hi gh 
den si ty li pop ro tein (HDL) cho les te rol, crea ti ni ne, 
C-reac ti ve pro tein (CRP), glu co se, gam ma-glu ta-
myltran sfe ra se (GGT), iron, inor ga nic phos pha te 
and uric acid (10). The frequen cy of pa rap ro tein in-
ter fe ren ce was re por ted to be ve ry ra re. Even so, 
so me syste ma tic stu dies on to tal bi li ru bin, di re ct 
bi li ru bin and HDL-cho les te rol showed the re ver se. 
It shou ld be ke pt in mi nd that when an in ter fe ren-
ce oc cu rs wi th one as say, it wi ll not ne ces sa ry bias 
anot her met hod mea su ri ng the sa me ana lyte (10). 
So me tec hno lo gies li ke the Mic roS li de tec hno lo gy 
has mi ni mal, or is free of in ter fe ren ce, be cau se the 
sam ple has to pa ss spe cial laye rs that crea tes an 
ul tra 1 l tra te. The in ter fe ri ng sub stan ce is 1 l te red 
out in this way of sam ple treat me nt (11,12).
Qua li ty con trol and mat rix e( e ct
For qua li ty con trol pro ce du res in the ana lyti cal pha-
se, the la bo ra to ry ve ry of ten, if not always, uses qua li-
ty con trol ma te rial that shou ld mi mic a pa tie nt sam-
ple. Mo st qua li ty con trol ma te ria ls are ma de from ar-
ti 1  cial sour ces, rat her di2 e re nt from hu man sam ples. 
Fir st, the ma te rial is 1 l te red, lyop hi li zed, sta bi li zed 
and ve ry of ten ana lytes from ani ma ls or synthe tic 
ori gin is ad ded. A la ck of com mu ta bi li ty be tween 
met ho ds and in stru men ts is known in the 1 e ld of 
qua li ty con trol for a wi de ran ge of ana lytes. An exam-
ple from a PT sur vey from the DGKL (Ger man So cie ty 
for Cli ni cal Che mis try and La bo ra to ry Me di ci ne) is 
shown in 1  gu re 3. Two pro 1  cien cy tes ti ng sam ples A 
and B wi th di2 e re nt con cen tra tio ns of cho les te rol 
we re se nt out to se ve ral la bo ra to ries. A sma ll group 
of la bo ra to ries fai led due to the prob lem of mat rix ef-
fec ts in the exter nal qua li ty con trol ma te rial whi le 
the in ter nal qua li ty con trol mate rial did not show the 
sa me e2 e ct. Ad di tio nal tes ti ng of this met hod in 
ques tion com pa red to a re fe ren ce met hod pro vi ded 
a ni ce cor re la tion if na ti ve pa tie nt ma te rial was used.
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Ca lib ra tion
The ca lib ra tion is the 1 r st and fo re mo st step in the 
ana lyti cal pro ce ss of the met hod or in stru me nt 
prior to the mea su re me nt of qua li ty con trol ma te-
rial or pa tie nt sam ples. Ve ry of ten the ope ra tor is 
unab le to han dle a pi pet te in the cor re ct way and 
mig ht the re fo re dis sol ve the lyop hi li zed ca lib ra tor 
ma te rial wi th the wro ng amou nt of sol ve nt. As su-
ch, it is pi vo tal to fol low stric tly the re com men da-
tio ns of the ma nu fac tu rer. The mul ti poi nt ca lib ra-
tor is usual ly mu ch bet ter com pa red to a sin gle or 
two poi nt ca lib ra tion. Ve ry of ten the met hod is ca-
lib ra ted wi th ca lib ra to rs that ha ve di2 e re nt ana-
lytes then tho se mea su red af te rwar ds. An exam-
ple is the use of al bu min in a ca lib ra tor to ca lib ra te 
the to tal pro tein as say.
In 2004 the Cli ni cal La bo ra to ry Stan dar ds In sti tu te 
(CLSI) re por ted the im pa ct of mea su re me nt un cer-
tain ties (13) that great ly in crea se the cos ts in heal-
thca re. A stu dy on ca lib ra tion of cal cium met ho ds 
was used to des cri be the cos ts of er ro rs in cal cium 
con cen tra tion when the ca lib ra tion wa sn’t do ne 
pro per ly. A sum of an nual ly ad di tio nal cos ts of $ 
60–199 mil lion was cal cu la ted when the ca lib ra-
tion was not do ne cor rec tly.
Drug (ana lyti cal) in ter fe ren ces
Any e2 e ct on the ana lyti cal pha se that is crea ted 
from a sub stan ce that is not the ana lyte to be de-
ter mi ned may con si de red as an ana lyti cal in ter fe-
ren ce. The to tal num ber of pub lis hed and the re fo-
re known drug in ter fe ren ces is rat her hi gh. The 
knowled ge of la bo ra to ry sta 2  and cli ni cia ns that 
dru gs may cau se fal se ly ele va ted, fal se ly nor mal 
and fal se ly lower va lues in cli ni cal pa tie nt ma te rial 
is ve ry of ten over loo ked or un known. Re por ts on 
the in ter fe ren ce of me ta bo li tes, re sul ti ng from the 
con ver sion of the mot her drug in to its me ta bo li tes 
is extre me ly ra re. Stu dies on the e2 e ct of se ve ral 
dru gs and their re sul ti ng me ta bo li tes in pa tien ts 
re cei vi ng two, three or even mo re dru gs at the sa-
me ti me are al so avai lab le in sin gle re por ts, on ly. In 
mo st ca ses, it is the ma nu fac tu rer of the rea gen ts 
who ta kes ca re of the drug in ter fe ren ces. The re is 
no real re por ti ng system avai lab le that col lec ts the 
da ta about in ter fe ren ces from dru gs and their me-
ta bo li tes. In 2006, You ng and Trydi ng crea ted a 
com mon da ta ba se that com bi nes e2 ec ts of di sea-
ses on ana lytes, im pa ct of her bs to cli ni cal diag-
nos tic tes ts, ana lyti cal in ter fe ren ces, bio lo gi cal ef-
fec ts as we ll as pre-a na lyti cal is sues. This da ta ba se 
is the lar ge st col lec tion of da ta on tho se prob le ms. 
Due to so me rea so ns, the da ta ba se is no lon ger 
avai lab le, thou gh the re are so me boo ks fo cu si ng 
the in ter feren ce and e2 ec ts of dru gs (14,15).
On ly cli ni cal che mis ts, the diag nos tic in dus try and 
me di cal tec hni cia ns are the use rs of the in for ma-
tion da ta ba se so far. It is howe ver im por ta nt that 
exper ts in cli ni cal set tin gs, as we ll as the phar ma-
ceu ti cal area, are in for med about this in for ma tion 
and tool. One of the 1 r st use rs of a com bi na tion of 
lab re sul ts and drug pres crip tion was pub lis hed by 
Fried man et al. (16). In ge ne ral, they fou nd a po si ti ve 
res pon se of the cli ni cia ns for the au to ma tic mo ni to-
ri ng of dru g-te st in ter fe ren ces or in te rac tio ns. The 
system had bo th an edu ca tio nal and cli ni cal va lue. 
A new ap proa ch was un der ta ken by Kai la jär vi et al. 
(17) in 2000, who com bi ned the in for ma tion they 
got fo rm the hos pi tal phar ma cy wi th lab reques ts 
and lab re sul ts. In their mo del a da ta ba se wi th on li-
ne sup po rt in drug e2 ec ts on hor mo ne te st re sul ts 
was cho sen. In 11% of the re sul ts they we re ab le to 
FI GU RE 3. Pro 1  cien cy tes ti ng re su lt of two sam ples wi th di2 e-
rent cho les te rol con cen tra tion. Due to mat rix e2 e ct of the qua-
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gi ve a war ni ng re min der. In 74% of all ca ses ad di tio-
nal tes ti ng or exa mi na tio ns of the pa tie nt ha ve 
been avoi ded. This stu dy is al so a good exam ple to 
re du ce cos ts in heal thca re and pro vi de mo re re liab-
le te st re sul ts for a bet ter treat me nt of the pa tie nt. 
In the fu tu re, mo re fo cus shou ld be paid by de sig-
ner dru gs on her bs and al so ge ne tic mo di 1 ed food 
that may ha ve an im pa ct to la bo ra to ry te st re sul ts.
La be li ng of spe ci men
Phle bo to mis ts, doc to rs and nur ses need an edu-
ca tion re gar di ng the ap prop ria te pro ce du re for 
blood col lec tion, as we ll as how to la bel the spe ci-
men. Any per son who draws a pa tie nt sam ple mu-
st la bel the tu be at the pa tien t ś bed si de wit hout 
ta ki ng the tu be in to a di2 e re nt pla ce. Whe ne ver 
pos sib le, an au to ma tic la be li ng is hel pful to avoid 
any iden ti 1  ca tion er ror. Han dwrit ten la be ls shou ld 
be avoi ded as they crea te mis rea di ng. The re are 
new iden ti 1  ca tion too ls li ke Ra dio Frequen cy Iden-
ti 1  ca tion (RFID) avai lab le that help pre ven ti ng mis-
la be li ng. The sa me is true in the ana lyti cal pro ce ss 
if sam ples are ta ken from the pri ma ry tu be and 
tran sfer red in to a se con da ry tu be. For mo de rn au-
to ma ted syste ms and lab au to ma tion, the clear 
iden ti 1  ca tion is a mu st. De vi ces, li ke the RFID is 
one so lu tion to avoid mis rea di ng.
Sta tis ti cal ana lysis
In eva lua tion stu dies of met ho ds, one usual ly com-
pa res the new met hod or new in stru me nt ver sus 
the old one. The re su lt of the met hod com pa ri son 
is usual ly pre sen ted in x-y-plot and the sta tis ti cal 
ana lysis is per for med ac cor di ng the requi re men ts 
of the scien ti 1 c jour nal in whi ch the stu dy shou ld 
be pub lis hed. In the exam ple shown in 1  gu re 4 we 
can see a ni ce cor re la tion and good sta tis ti cal da-
ta. If we do an ad di tio nal re la ti ve bias-plot, we wi ll 
re cei ve mu ch mo re de tai ls as shown in 1  gu re 5. In 
this exam ple it see ms a bit stran ge that the stu dy 
in vol ved main ly sam ples wi th low glu co se con cen-
tra tion. We can not see any nor mal dis tri bu tion of 
the in ves ti ga ted glu co se con cen tra tio ns and in the 
re la ti ve bia s-plot we ob ser ve a stro ng po si ti ve bias 
of the met hod B. In stead of de li ver on ly the x-y-
plot ad di tio nal in for ma tion is requi red to bet ter 
un der sta nd the cor re la tion we did.
Met hod eva lua tion
When the la bo ra to ry con si de rs buyi ng a new in-
stru me nt or usi ng a new met hod, it is sup po sed to 
run an eva lua tion stu dy 1 r st. Pre ci sion da ta we re 
usual ly ob tai ned by run ni ng eit her pa tie nt or qua-
li ty con trol ma te rial. So me ti mes the lab mig ht per-
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fo rm a li nea ri ty stu dy to con 1  rm the ma nu fac tu res 
da ta. In com pa ri son stu dies of ma nu fac tu res it is 
used ve ry of ten the sa me tec hno lo gy or da ta are 
com pa red wi th tho se of for mer in stru men ts by the 
sa me com pa ny and, in he ren tly, the cor re la tion is 
1  ne. Mu ch mo re in te res ti ng is howe ver com pa ri-
son wi th ot her tec hno lo gies, to bet ter de te ct any 
in ter fe ren ce or di2 e ren ce. This may he lp to de te ct 
er ro rs or at lea st sta rt col la bo ra tion be tween the 
la bo ra to ry and the diag nos tic in dus try to 1  nd the 
rea so ns for any de via tion.
Re lia bi li ty
An ar tic le about re lia bi li ty of scien ti 1 c pub lis hed 
da ta was pub lis hed in the jour nal Na tu re, in 2005 
(18). A ques tion nai re was se nt to 7,760 scien tis ts 
and they we re as ked about their be ha vior in their 
scien ti 1 c wo rk and pub li ca tio ns. The ques tion nai-
re was ano nymous and 3,247 scien tis ts an swe red 
it. Over 30% of the par ti ci pan ts con fes sed a ma ni-
pu la tion of their da ta. About 15.5% of the se par ti-
ci pan ts chan ged or mo di 1 ed the stu dy de si gn, the 
met hod or the re sul ts due to in ter ven tion of 1  nan-
cial sup po rt in the stu dy. Mo re than 12.5% igno red 
ques tio nab le in ter pre ta tio ns or in cor re ct re sul ts 
from col lea gues. Be cau se their re su lt did not 1 t in-
to the in ten ded out co me of the stu dy, 6% ho ld 
their re sul ts ba ck and did not use or pub li sh them.
Con clu sion
The on goi ng e2 or ts to re du ce me di cal er ro rs and 
en han ce pa tie nt sa fe ty can be di rec ted towa rd 
ma ny heal th ca re pro ces ses. Cli ni cal diag nos tic la-
bo ra to ries re cog ni zed ri sk areas wi th hi gh po ten-
tial for er ror ge ne ra tion. It is pru de nt that maxi-
mum e2 or ts are di rec ted towa rd pre ven ti ng er ro rs 
in areas of hi gh pre ven ta bi li ty. The hu man fac to rs 
in vol ved in ge ne ra ti ng er ro rs in the se spe cial ties 
de ser ve prio ri ty, and ap prop ria te tec hno lo gy may 
play a vi tal ro le in mi ni mi zi ng ma ny of the se fac to-
rs. The re gu la to ry and le gis la ti ve bo dies ha ve a 
central ro le in ad dres si ng ma ny of the se pa tie nt 
sa fe ty is sues. The exam ples gi ven in this pa per wi ll 
he lp to bet ter un der sta nd the sour ce of er ro rs and 
o2 e rs va luab le op tio ns and op por tu ni ties to pre-
ve nt them. The knowled ge of the rea so ns for de-
via tio ns and er ro rs wi ll re su lt in lower ris ks for the 
pa tie nt sa fe ty. Even if the ana lyti cal pro ce ss has a 
sma ll im pa ct on the to tal num ber of er ro rs in la bo-
ra to ry me di ci ne, ana lyti cal er ro rs shou ld be mi ni-
mi zed as mu ch as pos sib le. A new da ta ba se for 
drug in ter fe ren ces, e2 ec ts of her bs and any pre-a-
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na lyti cal er ro rs wi ll he lp to avoid mis lea di ng re sul ts. 
Ad di tio nal sta tis ti cal ana lysis and the pro per way of 
showi ng the di2 e ren ces in met hod com pa ri son wi ll 
he lp for bet ter in ter pre ta tion of da ta and avoi di ng 
wro ng repor ti ng of pa tie nt re sul ts. In crea se in 
knowled ge of the ca lib ra tion pro ce ss sa ves ad di tio-
nal mo ney for extra tes ti ng or wro ng treat me nt of 
the pa tie nt. The qua li ty con trol pro ce ss in the cli ni-
cal la bo ra to ry hel ps avoi di ng er ro rs but the cor re ct 
ma te rial has to be se lec ted to im pro ve a bet ter 
com mu ta bi li ty. Fi nal ly the re fe ren ce in ter val for the 
po pu la tion the la bo ra to ry has to be up da ted and 
cor re ct if nee ded. Ot he rwi se the re fe ren ce in ter val 
is of li mi ted va lue for the cli ni cian.
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Kva li te ta u ana li tič koj fa zi
Sa že tak
U da naš njem je sus ta vu zdrav stve ne skr bi pre va len ci ja pog re ša ka u me di ci ni vi so ka pre ma iz vješ ću In sti tu ta za me di ci nu (en gl. In sti tu te of Me-
di ci ne, IOM). U li te ra tu ri se dos ljed no iz vješ ta va o sto pi pog re ša ka od oko 10% u kli nič kim me di cin skim la bo ra to ri ji ma. Ve ći na se tih pog re ša ka 
do ga đa u pri jea na li tič koj fa zi. Bu du ći da se pog reš ke ri jet ko do ga đa ju u ana li tič koj fa zi, pos to ji opas no st da se one vr lo čes to za ne ma ru ju. Ovaj se 
preg led ba vi zah tje vi ma kva li te te ko ji se ne te me lje is klju či vo na is pi ti va nji ma kon trol nih uzo ra ka. Poz na va nje ana li tič kih in ter fe ren ci ja i kva li te te 
uzo ra ka nu di nam dra goc je na rje še nja za po bolj ša nje kva li te te cje lo kup nog pro ce sa la bo ra to rij skog is pi ti va nja. Ras prav ljat ćemo o ne kim po seb-
nim pod ruč ji ma ana li tič kog pro ce sa kao što su um je ra va nje, kon tro la kva li te te, re fe ren tni in ter va li, in ter fe ren ci je li je ko va, sta tis tič ka ana li za, pa-
rap ro tei ni i uči nak po re me ća ja vo lu me na. Na kon ne ko li ko prim je ra iz li te ra tu re i pri vat nih is kus ta va, bo lje će se mo ći ra zum je ti ut je caj pog re ša ka 
na ana li tič ki pro ces, te će ti prim je ri po mo ći u sma nje nju bro ja ana li tič kih pog re ša ka i in ter fe ren ci ja, ka ko bi se osi gu ra la si gur no st bo les ni ka na 
pu no vi šem stup nju.
Ključ ne ri je či: ana li tič ke pog reš ke; si gur no st bo les ni ka; kli nič ki la bo ra to rij; kon tro la kva li te te; inter fe ren ci je li je ko va; um je ra va nje; pa rap ro tein; 
re fe ren tni in ter val
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